KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$48.9 million.

  • Biogen's Income towards Parent Company fell 11833.52% to -$48.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year decrease of 2078.79%. This contributed to the annual value of $1.3 billion for FY2025, which is 2078.79% down from last year.
  • As of Q4 2025, Biogen's Income towards Parent Company stood at -$48.9 million, which was down 11833.52% from $466.5 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Income towards Parent Company ranged from a high of $1.1 billion in Q3 2022 and a low of -$134.8 million during Q3 2021
  • Moreover, its 5-year median value for Income towards Parent Company was $395.3 million (2023), whereas its average is $392.4 million.
  • Per our database at Business Quant, Biogen's Income towards Parent Company plummeted by 12874.51% in 2021 and then surged by 94836.8% in 2022.
  • Biogen's Income towards Parent Company (Quarter) stood at -$101.7 million in 2021, then skyrocketed by 649.66% to $559.0 million in 2022, then plummeted by 55.47% to $248.9 million in 2023, then increased by 7.15% to $266.7 million in 2024, then crashed by 118.34% to -$48.9 million in 2025.
  • Its last three reported values are -$48.9 million in Q4 2025, $466.5 million for Q3 2025, and $634.8 million during Q2 2025.